Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma

BACKGROUND: This study of the oropharyngeal microbiome complements the previously published AZIthromycin in Severe ASThma (AZISAST) clinical trial, where the use of azithromycin was assessed in subjects with exacerbation-prone severe asthma. Here, we determined the composition of the oropharyngeal m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes dos Santos Santiago, Guido, Brusselle, Guy, Dauwe, Kenny, Deschaght, Pieter, Verhofstede, Chris, Vaneechoutte, Dries, Deschepper, Ellen, Jordens, Paul, Joos, Guy, Vaneechoutte, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424369/
https://www.ncbi.nlm.nih.gov/pubmed/28486933
http://dx.doi.org/10.1186/s12866-017-1022-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424369/
https://www.ncbi.nlm.nih.gov/pubmed/28486933
http://dx.doi.org/10.1186/s12866-017-1022-6

Ejemplares similares